2.5.1.26	(3S)-3-(2-fluorophenyl)-N-((2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)methyl)butanamide	-	253011	
2.5.1.26	2,4-dinitrofluorobenzene	1 mM, 2% activity	7981	
2.5.1.26	2-oxo-3-(phosphonooxy)propyl hexadecanoate	inhibitory above 0.1 mM	111630	
2.5.1.26	3-(2,6-difluorophenyl)-N-((2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)methyl)butanamide	the inhibitor show higher binding affinity but retains the binding mode observed for (3S)-3-(2-fluorophenyl)-N-((2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)methyl)butanamide with the second fluorine atom likely enhancing the hydrophobic interactions with the aliphatic residues surrounding the substrate tunnel	253012	
2.5.1.26	3-Bromo-2-oxoheptadecyl phosphate	-	91379	
2.5.1.26	acyldihydroxyacetone phosphate	high concentration, substrate inhibition	29699	
2.5.1.26	fatty acids	competitive to fatty alcohols	2739	
2.5.1.26	fatty acids	-	2739	
2.5.1.26	hexadecanol	inhibitory above 0.3 mM	1379	
2.5.1.26	Mg2+	5 mM, 70% activity	6	
2.5.1.26	Mn2+	5 mM, 6% activity	11	
2.5.1.26	additional information	not inhibitory: Ca2+	2	
2.5.1.26	N-ethylmaleimide	5 mM, 15% activity	49	
2.5.1.26	NaCl	50% inhibition at 0.6 M	42	
2.5.1.26	p-bromophenacylbromide	1 mM, 55% activity	10743	
2.5.1.26	Phenylglyoxal	inactivation	301	
2.5.1.26	Zn2+	5 mM, 8% activity	14